Dafna Capital Management LLC Uro Gen Pharma Ltd. Transaction History

Dafna Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$16.5 - $29.7 $39,088 - $70,359	-2,369 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$13.68 - $34.6 $22,134 - $55,982	-1,618 Reduced 40.58%	2,369 $42,000
Q4 2019 Feb 14, 2020	SELL	$21.11 - $34.86 $232,484 - $383,913	-11,013 Reduced 73.42%	3,987 $133,000
Q3 2018 Nov 14, 2018	BUY	$41.65 - $51.7 $208,250 - $258,500	5,000 Added 50.0%	15,000 $708,000
Q2 2018 Aug 13, 2018	BUY	$48.35 - $65.33 $265,925 - $359,315	5,500 Added 122.22%	10,000 $498,000

Q1 2018 May 15, 2018	BUY	$38.64 - $57.54 $173,880 - $258,930	4,500 New	4,500 $224,000

113

24M

46.9K

44.3K

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $373M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Dafna Capital Management LLC with notifications on news.